NY-ESO-1 vaccine (Instituto Butantan)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNY-ESO-1 vaccine (Instituto Butantan)
Drug Alias NameN/A
ClassificationBiologics > Antigen > Tumor antigenVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide +[4] 
Mechanisms of ActionCancer/testis antigen 1 modulators
TargetsCancer/testis antigen 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstituto Butantan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstituto Butantan
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A